ArticleOncoTargets and therapy2022

MicroRNA-217 Acts as a Tumor Suppressor and Correlates with the Chemoresistance of Cervical Carcinoma to Cisplatin [Expression of Concern].

No numbers read from the abstract.

Not cited yet